BlackRock Institutional Trust’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

BlackRock Institutional Trust’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-541,906	Closed	-$11.3M	–	3960
2016 Q3	$11.3M	Sell	541,906 -28,751	-5%	-$331K	﹤0.01%	2271
2016 Q2	$6.16M	Buy	570,657 +187,617	+49%	+$1.6M	﹤0.01%	2569
2016 Q1	$2.54M	Buy	383,040 +74,558	+24%	+$678K	﹤0.01%	2949
2015 Q4	$5.58M	Buy	308,482 +7,061	+2%	+$97.2K	﹤0.01%	2656
2015 Q3	$3.32M	Buy	301,421 +79,127	+36%	+$841K	﹤0.01%	2907
2015 Q2	$3.2M	Sell	222,294 -44,853	-17%	-$609K	﹤0.01%	2930
2015 Q1	$3.13M	Buy	+267,147	New	+$3.6M	﹤0.01%	2929

BlackRock Institutional Trust's VTAE Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 541,906 shares — an estimated $11.3M sold.

BlackRock Institutional Trust first reported a position in VTAE in Q1 2015 and held it in 7 quarters. The position peaked at $11.3M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

BlackRock Institutional Trust reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
BlackRock Institutional Trust sold 541,906 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $11.3M.
BlackRock Institutional Trust first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 7 quarters.
BlackRock Institutional Trust's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $11.3M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.